328 related articles for article (PubMed ID: 37719965)
1. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022).
You H; Wang F; Li T; Xu X; Sun Y; Nan Y; Wang G; Hou J; Duan Z; Wei L; Jia J; Zhuang H;
J Clin Transl Hepatol; 2023 Nov; 11(6):1425-1442. PubMed ID: 37719965
[TBL] [Abstract][Full Text] [Related]
2. [Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)].
;
Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1309-1331. PubMed ID: 36891718
[TBL] [Abstract][Full Text] [Related]
3. [Research progress on clinical antiviral treatment of chronic hepatitis B in children].
; ; ;
Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):435-448. PubMed ID: 38858193
[TBL] [Abstract][Full Text] [Related]
4. [Guidelines for the prevention and treatment of hepatitis C (2019 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):962-979. PubMed ID: 31941258
[TBL] [Abstract][Full Text] [Related]
5. [Guideline for the prevention and treatment of hepatitis C (2022 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1332-1348. PubMed ID: 36891719
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for Prevention and Treatment of Chronic Hepatitis B.
Wang G; Duan Z
J Clin Transl Hepatol; 2021 Oct; 9(5):769-791. PubMed ID: 34722192
[TBL] [Abstract][Full Text] [Related]
7. [Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022)].
You H; Sun YM; Zhang MY; Nan YM; Xu XY; Li TS; Wang GQ; Hou JL; Duan ZP; Wei L; Wang FS; Jia JD; Zhuang H
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):385-388. PubMed ID: 37248977
[TBL] [Abstract][Full Text] [Related]
8. [Interpretation of the important update of the Guideline for the prevention and treatment of hepatitis C (2022 edition)].
Rao HY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2023 Jul; 31(7):688-691. PubMed ID: 37580249
[TBL] [Abstract][Full Text] [Related]
9. [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):938-961. PubMed ID: 31941257
[TBL] [Abstract][Full Text] [Related]
10. Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022).
Liu Z; Chen Z; Cui F; Ding Y; Gao Y; Han G; Jia J; Li J; Li Z; Liu Y; Mao Q; Wang A; Wang W; Wei L; Xia J; Xie Q; Yang X; Yin X; Zhang H; Zhang L; Zhang W; Zhuang H; Dou X; Hou J
J Clin Transl Hepatol; 2022 Oct; 10(5):1004-1010. PubMed ID: 36304493
[TBL] [Abstract][Full Text] [Related]
11. Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus.
Hou J; Cui F; Ding Y; Dou X; Duan Z; Han G; Jia J; Mao Q; Li J; Li Z; Liu Z; Wei L; Xie Q; Yang X; Zhang H; Zhuang H
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1929-1936.e1. PubMed ID: 30312789
[TBL] [Abstract][Full Text] [Related]
12. [Management algorithm for prevention of mother-to-child transmission of hepatitis B virus (2021)].
; ;
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):313-318. PubMed ID: 33979956
[TBL] [Abstract][Full Text] [Related]
13. [Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)].
Rao HY; Duan ZP; Wang GQ; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):129-132. PubMed ID: 32164062
[TBL] [Abstract][Full Text] [Related]
14. The urgency to expand the antiviral indications of general chronic hepatitis B patients.
Fan P; Li LQ; Chen EQ
Front Med (Lausanne); 2023; 10():1165891. PubMed ID: 37275355
[TBL] [Abstract][Full Text] [Related]
15. Trends in mortality of liver disease due to hepatitis B in China from 1990 to 2019: findings from the Global Burden of Disease Study.
Cao G; Liu J; Liu M
Chin Med J (Engl); 2022 Sep; 135(17):2049-2055. PubMed ID: 36228164
[TBL] [Abstract][Full Text] [Related]
16. [Discussion on the prevention and control strategies of chronic hepatitis B: experience from AIDS prevention and control in China].
Li J; Liu ZF
Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):402-405. PubMed ID: 38858189
[TBL] [Abstract][Full Text] [Related]
17. Interpretation of the National Action Plan for Eliminating Hepatitis C as a Public Health Threat (2021-2030).
Li J; Pang L; Liu Z
China CDC Wkly; 2022 Jul; 4(29):627-630. PubMed ID: 35919827
[TBL] [Abstract][Full Text] [Related]
18. Countdown to 2030: eliminating hepatitis B disease, China.
Liu J; Liang W; Jing W; Liu M
Bull World Health Organ; 2019 Mar; 97(3):230-238. PubMed ID: 30992636
[TBL] [Abstract][Full Text] [Related]
19. China's efforts to shed its title of "Leader in liver disease".
Li X; Xu WF
Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
[TBL] [Abstract][Full Text] [Related]
20. Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011.
Christensen PB; Clausen MR; Krarup H; Laursen AL; Schlichting P; Weis N; ;
Dan Med J; 2012 Jun; 59(6):C4465. PubMed ID: 22677253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
